Ledger.Open graph →

SEC Form D · filed December 17, 2020

Syros Pharmaceuticals, Inc

Offering

$121.6M

Sold

$90.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

CAMBRIDGE, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (37)

Eric C. Olson · Cambridge, MAExec Mark Alles · Cambridge, MADirector Srinivas Akkaraju · Cambridge, MADirector Peter Wirth · Cambridge, MADirector Nancy Simonian · Cambridge, MAExec · Director Richard A. Young · Cambridge, MADirector David C. Roth · Cambridge, MAExec Sue G. Eckhardt · Cambridge, MADirector Marsha A. Fanucci · Cambridge, MADirector Philip Sharp · San Francisco, CADirector Jeremy G. Springhorn · Cambridge, MAExec Gerald G. Quirk · Cambridge, MAExec Drew D. Weilbacher · LARKSPUR, CADirector M. H. Mullin · LARKSPUR, CAExec · Director Charles Esserman · LARKSPUR, CADirector James L. O'Hara · LARKSPUR, CADirector Pierre H. Lecomte · LARKSPUR, CADirector Edward D. Wong · LARKSPUR, CAExec William D. Cooling · LARKSPUR, CADirector Irena D. Blind · LARKSPUR, CAExec Jennifer B. Moser · LARKSPUR, CADirector Joseph G. Ferra, Jr · Cambridge, MAExec Amir Nashat · Cambridge, MADirector Joon Chang · Stamford, CTDirector Tyler Stowater · Colmbus, OHDirector Peter Valenti · Colmbus, OHDirector Brad Beasecker · Columbus, OHDirector Richard Lindstrom · Columbus, OHExec Richard Heinick · Columbus, OHExec Robin Sears · Columbus, OHDirector Joseph H. Coyne · Dripping Springs, TXExec · Director Scott Birnbaum · New York, NYDirector Philip Sharp · San Francisco, CADirector Jeremy G. Springhorn · Cambridge, MAExec Gerald G. Quirk · Cambridge, MAExec Joseph G. Ferra, Jr · Cambridge, MAExec Amir Nashat · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗